InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by ARCH Venture Partners X, LLC. Insider active across 4 companies, notably Verve Therapeutics, Inc.. Cumulatively, 10 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €31.7m. Activity tracked since 15 February 2024. The latest transaction was disclosed on 27 October 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to ARCH Venture Partners X, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
1,915,700 股@ US$2.61100.0% 占其流量Common StockSEC:0001012975-25-000679:0
标准退出：2026年1月25日 (T+90)
3,030,300 股@ US$3.3032.0% 占其流量Common StockSEC:0001062993-25-013460:0
标准退出：2025年10月30日 (T+90)
3,200,000 股@ US$6.25100.0% 占其流量Common StockSEC:0001062993-24-003738:0
标准退出：2024年5月15日 (T+90)
703,061 股Common StockSEC:0001062993-23-022480:0
1,176,593 股Common StockSEC:0001062993-23-022480:1
684,167 股Common StockSEC:0000899243-23-019273:0
684,167 股Common StockSEC:0000899243-23-019274:0
5,728,297 股Common StockSEC:0001628280-22-027125:0
5,527,777 股Common StockSEC:0000899243-21-029077:0
1,254,404 股Common Stock, par value $0.001SEC:0000899243-21-025507:0
10 条申报中的 10 条
About ARCH Venture Partners X, LLC
ARCH Venture Partners X, LLC is a declarant linked to Neumora Therapeutics, Inc., Prime Medicine, Inc., Erasca, Inc. and Verve Therapeutics, Inc. The record shows 10 filings in total, with buy volume in the sampled recent filings from 2021-06-23 to 2025-10-29 of EUR 31687871 and no reported sells.
